Home Tags Checkpoint Inhibitor

Tag: Checkpoint Inhibitor

Seattle Genetics and Astellas Pharma Evaluate Enfortumab Vedotin as Monotherapy in...

Seattle Genetics and Astellas Pharma today confirmed dosing the first patient in EV-201, a registrational phase II clinical trial of enfortumab vedotin as a...

Phase II Study of Single-agent Glembatumumab Vedotin in Patients with Checkpoint-Refractory...

Positive, mature, results from a Phase II study of glembatumumab vedotin (Celldex Therapeutics) in patients with stage III/IV checkpoint inhibitor-refractory, and, if applicable, BRAF/MEK...
Featured Image: Nyhavn, Copenhagen, Denmark. Courtesy: © Fotolia. Used with permission.

Glembatumumab vedotin Shows Encouraging anti-tumor Activity Checkpoint Inhibitor-refractory Metastatic Melanoma

Results from a phase II trial presented in a poster at the annual meeting of the European Society of Medical Oncology, held in Copenhagen,...

Targeting Breast Cancer with more Punch

To optimize current treatment and develop methods to more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells...